Rituxan Can in Rare Cases Lead to Very Low Platelet Levels in ANCA Vasculitis Patients, Study Says
Patients with ANCA-associated vasculitis might develop acute thrombocytopenia — extremely low levels of platelets circulating in the blood — after being treated with Rituxan (rituximab), a case study from Japan reported for a first time. While rare, physicians should be aware of this potential side effect so as to detect…